On September 2, 2022, Genome & Company closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7,180 KRW | 0.00% | +4.82% | -42.51% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
13,880 KRW | +0.29% | +2.06% | 8.08B | ||
8,100 KRW | +7.28% | +9.31% | 2.88B | ||
1st Jan change | Capi. | |
---|---|---|
-42.51% | 78.75M | |
+17.96% | 47.02B | |
+48.77% | 41.86B | |
+1.17% | 41.76B | |
-4.27% | 28.8B | |
+11.42% | 26.05B | |
-21.39% | 19.15B | |
+4.86% | 12.55B | |
+27.29% | 12.34B | |
-3.50% | 11.82B |
- Stock Market
- Equities
- A314130 Stock
- News Genome & Company
- Genome & Company announced that it has received KRW 34.34975035 billion in funding from a group of investors